[(p-MeC6H4Pri)2Ru2(SC6H4-p-But)3]Cl (diruthenium-1), a dinuclear arene ruthenium compound with very high anticancer activity: An in vitro and in vivo study

Journal of Organometallic Chemistry

Volumn 782, Issue , 2015, Pages 42-51

  Tomšík, Pavel ^a   Muthná, Darina ^a   Řezáčová, Martina ^a   Mičuda, Stanislav ^a   Ćmielová, Jana ^a   Hroch, Miloš ^a   Endlicher, René ^a   Červinková, Zuzana ^a   Rudolf, Emil ^a   Hann, Stephan ^b   Stíbal, David ^c   Therrien, Bruno ^c   Süss Fink, Georg ^c  

^a CHARLES UNIVERSITY   (Czech Republic)

^b UNIVERSITY OF NATURAL RESOURCES AND LIFE SCIENCES   (Austria)

^c UNIVERSITY OF NEUCHÂTEL   (Switzerland)

Author keywords

Anticancer activity; In vitro and in vivo study; Ruthenium complexes

Indexed keywords

CATALYTIC OXIDATION; CELL CULTURE; CELLS; CYTOLOGY; CYTOTOXICITY; DISEASES; MAMMALS; OXIDATION; PEPTIDES; PLATINUM COMPOUNDS; RUBIDIUM COMPOUNDS; RUTHENIUM; RUTHENIUM COMPOUNDS; TUMORS;

ANTICANCER ACTIVITIES; HUMAN BREAST CANCER CELLS; IN-VITRO; INTRACELLULAR CONCENTRATION; MAXIMUM TOLERATED DOSE; MITOCHONDRIAL RESPIRATION; POSITIVE CONTROL GROUP; RUTHENIUM COMPLEXES;

CHLORINE COMPOUNDS;

ANIMALIA; MUS;

EID: 84925431451     PISSN: 0022328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jorganchem.2014.10.050     Document Type: Article

References (45)

1. J. Reedijk Eur. J. Inorg. Chem. 2009 1303 1312
2. J. Reedijk Chem. Commun. 1996 801 806
3. E. Wong, and C.M. Giandomenico Chem. Rev. 99 1999 2451 2466
4. M. Galanski, M.A. Jakupec, and B.K. Keppler Curr. Med. Chem. 12 2005 2075 2094
5. I. Bratsos, St Jedner, T. Gianferrara, and E. Alessio Chimia 61 2007 692 697
6. J. Reedijk Platin. Met. Rev. 52 2008 2 11
7. C.S. Allardayce, and P.J. Dyson Platin. Met. Rev. 45 2001 62 69
8. P.J. Dyson, and G. Sava Dalton Trans. 2006 1929 1933
9. C.S. Allardayce, A. Dorcier, C. Scolaro, and P.J. Dyson Appl. Organomet. Chem. 19 2005 1 10
10. H. Keller, B. Keppler, US Patent, 1989, 4843069;
11. cf. B.K. Keppler, K.-G. Lipponer, B. Stenzel, F. Kratzin, in: B. K. Keppler (Ed.), Metal Complexes in Cancer Chemotherapy, VCH Weinheim, 1993, 187.
12. G. Mestroni, E. Alessio, G. Sava, Int. Patent, 1998, PCT C 07F 15/00, A61K 31/28, WO 98/00431;
13. cf. G. Mestroni, E. Alessio, G. Sava, S. Pacor, M. Coluccia, in: B.K. Keppler (Ed.), Metal Complexes in Cancer Chemotherapy, VCH Weinheim, 1993, 157.
14. R. Trondl, P. Heffeter, C.R. Kowol, M.A. Jakupec, W. Berger, and B.K. Keppler Chem. Sci. 5 2014 2925 2932
15. G. Süss-Fink Dalton Trans. 39 2010 1673 1688
16. L.D. Dale, J.H. Tocher, T.M. Dyson, D.I. Edwards, and D.A. Tocher Anti-Cancer Drug Des. 7 1992 3 14
17. P.J. Dyson Chimia 61 2007 698 703
18. S.J. Dougan, and P.J. Sadler Chimia 61 2007 704 715
19. C.S. Allardyce, P.J. Dyson, D.J. Ellis, and S.L. Heath Chem. Commun. 2001 1396 1397
20. R.E. Morris, R.E. Aird, P. d. S. Murdoch, H. Chen, J. Cummings, N.D. Hughes, S. Pearsons, A. Parkin, G. Boyd, D.I. Jodrell, and P.J. Sadler J. Med. Chem. 44 2001 3616 3621
21. M.-G. Mendoza-Ferri, C.G. Hartinger, R.E. Eichinger, N. Stolyarova, K. Severin, M.A. Jakupec, A.A. Nazarov, and B.K. Keppler Organometallics 27 2008 2405 2407 M.-G. Mendoza-Ferri, C.G. Hartinger, A.A. Nazarov, W. Kandioller, K. Severin, B.K. Keppler, Appl. Organomet. Chem. 22 (2008) 326-332
22. M.-G. Mendoza-Ferri, C.G. Hartinger, M.A. Mendoza, M. Groessl, A.E. Egger, R.E. Eichinger, J.P. Mangrum, N.P. Farrell, M. Maruszak, P.J. Bednarski, F. Klein, M.A. Jakupec, A.A. Nazarov, K. Severin, and B.K. Keppler J. Med. Chem. 52 2009 916 925
23. K. Mashima, A. Mikami, and A. Nakamura Chem. Lett. 1992 1795 1798
24. H.T. Schacht, R.C. Haltiwanger, and M. Rakowski DuBois Inorg. Chem. 31 1992 1728 1730
25. M. Gras, B. Therrien, G. Süss-Fink, O. Zava, and P.J. Dyson Dalton Trans. 39 2010 10305 10313
26. F. Giannini, J. Furrer, A.-F. Ibao, G. Süss-Fink, B. Therrien, O. Zava, M. Baquie, P.J. Dyson, and P. Štěpnička J. Biol. Inorg. Chem. 17 2012 951 960
27. G. Süss-Fink, B. Therrien, M. Gras, P. J. Dyson, O. Zava, A.-F. Ibao, Int. Patent Appl. WO 2012/010616 A1, 26.1.2012.
28. F. Giannini, G. Süss-Fink, and J. Furrer Inorg. Chem. 50 2011 10552 10554
29. S.J. Dougan, A. Habtemariam, S.E. McHale, S. Parsons, and P.J. Sadler Proc. Nat. Acad. Sci. U. S. A. 105 2008 11628 11633
30. F. Giannini, L.E.H. Paul, J. Furrer, B. Therrien, and G. Süss-Fink New. J. Chem. 37 2013 3503 3511
31. A.J. Taylor, and M. Wenzel Xenobiotica 8 1978 107 112
32. M.M. van Hennik, W.J. van der Vijgh, I. Klein, F. Elferink, J.B. Vermorken, B. Winograd, and H.M. Pinedo Cancer Res. 47 1987 6297 6301
33. J.C. Schuh Toxicol. Pathol. 32 Suppl. 1 2004 53 66
34. C. Scolaro, A. Bergamo, L. Brescacin, R. Defino, M. Cocchietto, G. Laurenczy, T.J. Geldbach, G. Sava, and P.J. Dyson J. Med. Chem. 48 2005 4161 4171
35. M. Pernot, T. Bastogne, N.P.E. Barry, B. Therrien, G. Koellensperger, S. Hann, V. Reshetov, and M. Barberi-Heyob J. Photochem. Photobiol. B 117 2012 80 89
36. M.V. Céspedes, I. Casanova, M. Parreño, and R. Mangues Clin. Transl. Oncol. 8 2006 318 329
37. D. Li, J.I. Williams, and R.J. Pietras Oncogene 21 2002 2805 2814
38. A.J. Litterman, D.M. Zellmer, K.L. Grinnen, M.A. Hunt, A.Z. Dudek, A.M. Salazar, and J.R. Ohlfest J. Immunol. 190 2013 6259 6268
39. J.A. Segura, L.G. Barbero, and J. Márquez FEBS Lett. 414 1997 1 6
40. J.F. Turrens J. Physiol. 552 2003 335 344
41. Y. Chen, M.Y. Qin, L. Wang, H. Chao, L.N. Ji, and A.L. Xu Biochimie 95 2013 2050 2059
42. Z. Zhao, Z. Luo, Q. Wu, W. Zheng, Y. Feng, and T. Chen Dalton Trans. 2014 Aug 4 (Epub ahead of print)
43. Since diruthenium-1 was used as HCl adduct (0.75 eq), the exact concentration values are: 0.19, 0.39, 0.58, 0.97 and 1.94 mg/kg.
44. R. Kand'ár, P. Záková, H. Lotková, O. Kucera, and Z. Cervinková J. Pharm. Biomed. Anal. 43 2007 1382 1387
45. E. Bustamante, J.W. Soper, and P.L. Pedersen Anal. Biochem. 80 1977 401 408